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FOREWORD
Helicobacterpylori Meeting-March 1-2, 1997
This meeting held at Yale University School of Medicine was sponsored by Abbott
Pharmaceuticals and the Yale University School of Medicine. A group of national and
international authorities were invited to participate in an evaluation ofthe current status of
the diagnosis and management ofHelicobacterpylori. The dramatic increase in relevance
of this pathogen belies its humble origins. Although initially noted at the turn of the cen-
tury by a number of clinicians and pathologists, they failed to appreciate its clinical and
pathological significance. In fact, it was not until observations of Barry Marshall and R.
Warren that an understanding of its pathological importance became apparent. In the fol-
lowing decade, studies from a wide variety of investigators further confirmed the major
role ofH. pylori not only in acid peptic disease but also as a pathogen implicated in the
genesis ofgastric carcinoma. The extraordinary expansion of studies both to elucidate its
biology as well as to develop targeted therapeutic strategies attest to its worldwide recog-
nition as a pathogen. Its recognition as a critical factor in the genesis ofulceration ofthe
duodenum and stomach has led to the introduction ofeffective diagnostic and therapeutic
strategies. Indeed, the utilization ofdifferentpharmacological regimes including acid sup-
pression and bacterial eradication has significantly altered the natural history ofacid pep-
tic disease. The combination of acid suppression and antibiotic therapy has proven to be
both well tolerated and efficacious. The successful introduction of such pharmacothera-
peutic intervention has not only significantly reduced the impact ofacidpeptic disease and
its recurrence but brought considerable focus to bear on the financial aspects of health
related well being as they pertain to the upper gastro-intestinal tract.
The paper presented at this meeting have been collated in a form that will allow for a
sense of the development of the issues regarding biology, diagnosis and therapy of H.
pylori. Although considerable information is available, there still remains controversy
regarding numerous issues relating both to the pathobiology and management of disease
engendered by H. pylori. The evaluation of information presented in this volume will
hopefully cast further light on a subject of considerable clinical relevance not only to
physicians and their patients but also to aspects ofthe economic issues involved in health-
care and work efficiency.
Irvin M. Modlin, M.D., Ph.D., FACS, FRCS
Hunterian Professor